0.5543USD+8.99%Mkt Cap: 7.08M $P/E: —2d ago
20/20 Biolabs, Inc. develops and commercializes AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. It provides OneTest for Cancer, a multi-cancer early detect…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap7.08M $
Enterprise Value2.74M $
Revenue (TTM)1.84M $
Gross Profit604.54K $
Net Income (TTM)-3.74M $
Revenue/Share0.3270 USD
Last Price0.5543 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees4
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-0.70
EV/Revenue1.48
P/S3.56
P/B-42.84
EPS (TTM)-0.59
EPS (Forward)—
52W Range
0.40110% of range50.00
52W High50.00 USD
52W Low0.4011 USD
Profitability
Gross Margin29.56%
Oper. Margin-408.45%
EBITDA Margin-212.60%
Profit Margin-182.82%
ROE19447.70%
ROA-90.37%
Growth
Revenue Growth-36.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.92M $
CapEx (TTM)—
FCF Margin-70.58%
FCF Yield-18.39%
Net Debt-3.29M $
Net Debt/EBITDA0.84
Balance Sheet
Debt/Equity-70.67
Current Ratio1.82
Quick Ratio1.71
Book Value/Sh-0.0120 USD
Cash/Share0.3980 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)5.000 USD
Upside (mean)+802.0%
Target Range5.000 USD – 5.000 USD
# Analysts1
Ownership
Shares Out.12.77M
Float8.95M
Insiders26.16%
Institutions4.41%
Short Interest
Short Ratio0.7d
Short % Float1.51%
Short % Out.1.25%
Shares Short153.29K
Short (prev mo.)186.86K
Technical
SMA 500.5554 (-0.2%)
SMA 2001.722 (-67.8%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)113.77K
Avg Vol (10d)96.73K
Technical Indicators
RSI (14)47.7
MACD-0.0226
MACD Signal-0.0448
MACD Hist.+0.0222
BB Upper0.5614 USD
BB Middle0.4716 USD
BB Lower0.3818 USD
BB Width38.09%
ATR (14)0.0539 USD
Vol Ratio (20d)0.40x